Marta Francesconi

Dr. Marta Francesconi

Department of Psychology and Human Development, UCL Institute of Education, London WC1H 0AL, UK

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
AMAmedeo Minichino
Amedeo Minichino
FBFrancesco Saverio Bersani
Francesco Saverio Bersani
WCWanda Katharina Calò
Wanda Katharina Calò
FSFrancesco Spagnoli
Francesco Spagnoli
MFMarta Francesconi
Marta Francesconi
MBMassimo Biondi
Massimo Biondi
Tobacco use is strongly associated with a variety of psychiatric disorders. Smokers are more likely than non-smokers to meet current criteria for mental health conditions, such as mood disorders, anxiety disorders and psychosis. Evidence also suggest that smokers with psychiatric disorders may have more difficulty quitting, offering at least a partial explanation for why smoking rates are higher in this population. The mechanisms linking mental health conditions and cigarette smoking are complex and likely differ across each of the various disorders. The most commonly held view is that patients with mental health conditions smoke in an effort to regulate the symptoms associated with their disorder. However some recent evidence suggests that quitting smoking may actually improve mental health symptoms. This is particularly true if the tobacco cessation intervention is integrated into the context of ongoing mental health treatment. In this paper we reviewed and summarized the most relevant knowledge about the relationship between tobacco use and dependence and psychiatric disorders. We also reviewed the most effective smoking cessation strategies available for patients with psychiatric comorbidity and the impact of smoking behavior on psychiatric medication.

1 January 2020 in Journal of Affective Disorders
Verified
Journal Article
Closed access
EFEirini Flouri
Eirini Flouri
MFMarta Francesconi
Marta Francesconi
EMEmily Midouhas
Emily Midouhas
GLGlyn Lewis
Glyn Lewis

17 May 2021 in Molecular Psychiatry
Verified
Journal Article
Open access
PDF file
AMAmedeo Minichino
Amedeo Minichino
MJMatthew A. Jackson
Matthew A. Jackson
MFMarta Francesconi
Marta Francesconi
CSClaire J. Steves
Claire J. Steves
CMCristina Menni
Cristina Menni
BLBelinda R. Lennox
Belinda R. Lennox
Anhedonia and amotivation are debilitating symptoms and represent unmet therapeutic needs in a range of clinical conditions. The gut-microbiome-endocannabinoid axis might represent a potential modifiable target for interventions. Based on results obtained from animal models, we tested the hypothesis that the endocannabinoid system mediates the association between gut-microbiome diversity and anhedonia/amotivation in a general population cohort. We used longitudinal data collected from 786 volunteer twins recruited as part the TwinsUK register. Our hypothesis was tested with a multilevel mediation model using family structure as random intercept. The model was set using alpha diversity (within-individual gut-microbial diversity) as predictor, serum and faecal levels of the endocannabinoid palmitoylethanolamide (PEA) as mediator, and anhedonia/amotivation as outcome. PEA is considered the endogenous equivalent of cannabidiol, with increased serum levels believed to have anti-depressive effects, while increased stool PEA levels, reflecting increased excretion, are believed to have opposite, detrimental, effects on mental health. We therefore expected that either reduced serum PEA or increased stool PEA would mediate the association between microbial diversity and anhedonia amotivation. Analyses were adjusted for obesity, diet, antidepressant use, sociodemographic and technical covariates. Data were imputed using multiple imputation by chained equations. Mean age was 65.2 ± 7.6; 93% of the sample were females. We found a direct, significant, association between alpha diversity and anhedonia/amotivation (β = −0.37; 95%CI: −0.71 to −0.03; P = 0.03). Faecal, but not serum, levels of the endocannabinoid palmitoylethanolamide (PEA) mediated this association: the indirect effect was significant (β = −0.13; 95%CI: −0.24 to −0.01; P = 0.03), as was the total effect (β = −0.38; 95%CI: −0.72 to −0.04; P = 0.03), whereas the direct effect of alpha diversity on anhedonia/amotivation was attenuated fully (β = −0.25; 95%CI: −0.60 to 0.09; P = 0.16). Our results suggest that gut-microbial diversity might contribute to anhedonia/amotivation via the endocannabinoid system. These findings shed light on the biological underpinnings of anhedonia/amotivation and suggest the gut microbiota-endocannabinoid axis as a promising therapeutic target in an area of unmet clinical need.

1 April 2019 in Journal of the American Academy of Child & Adolescent Psychiatry
Verified
Journal Article
Open access
EFEirini Flouri
Eirini Flouri
ZSZahra Sarmadi
Zahra Sarmadi
MFMarta Francesconi
Marta Francesconi
To explore whether paternal psychological distress is related to the longitudinal course of child problem behavior after accounting for maternal psychological distress. We used data from the Millennium Cohort Study (MCS), a large general-population birth cohort in the United Kingdom. Maternal and paternal psychological distress was measured with the Kessler 6-item Psychological Distress Scale (K-6) at child ages 3, 5, 7, 11, and 14 years. Problem behavior was measured with the Strengths and Difficulties Questionnaire at these ages. Data were analyzed using growth curve modeling, before and after adjustment for confounders (N = 13,442). The effect of paternal psychological distress was weaker than that of maternal psychological distress. However, even after adjustment for maternal psychological distress and confounding, paternal psychological distress predicted all four domains of child problem behavior that we examined (hyperactivity, conduct, emotional, and peer problems). Child problem scores were generally lower in biological father families, but the effect of paternal psychological distress was the same for children in biological and nonbiological father families and did not depend on the level of maternal psychological distress. High levels of paternal psychological distress predicted some problems (emotional symptoms and hyperactivity) more strongly in boys than in girls. There was evidence for a robust association between psychological distress in fathers and problem behavior in their offspring. Our findings suggest that the mental health of both fathers and mothers is important for the behavior of their children.

1 August 2019 in Brain, Behavior, and Immunity
Verified
Journal Article
Closed access
EFEirini Flouri
Eirini Flouri
MFMarta Francesconi
Marta Francesconi
SPSteven Papachristou
Steven Papachristou
EMEmily Midouhas
Emily Midouhas
GLGlyn Lewis
Glyn Lewis

1 July 2017 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
AMAmedeo Minichino
Amedeo Minichino
AAAgata Ando'
Agata Ando'
MFMarta Francesconi
Marta Francesconi
Adriana SalatinoAdriana Salatino
Adriana Salatino
RCRoberto Delle Chiaie
Roberto Delle Chiaie
KCKristin Cadenhead
Kristin Cadenhead